Sheel Biotech IPO

About the company

Incorporated in 1991, Sheel Biotech is engaged in growing, developing, processing, and supplying plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. The company has an R&D laboratory with a production capacity of 1 crore planting materials annually. In FY25, 90.5% of procurement was domestic, while the rest came from imports of "BLUE RIBBON" 2L pots from the Netherlands. It has completed 59 major projects with a cumulative contract value exceeding ₹150 crore across various segments and operates 12 ongoing projects with a total contract value exceeding ₹30 crore, expected to be completed by 2025-27. The company operates through 5 segments, with the landscaping and planting segment contributing 34.48% of revenue, followed by greenhouse and packhouse at 27.95%. Meanwhile, government tenders contributed 56.6% of revenue in FY25.

Financial performance (₹ Cr)

Subscription breakup (final, times)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   30 Sept 2025

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   03 Oct 2025

   Last day to place your bid

3. Basis of Allotment

   Completed
   06 Oct 2025

   Share allotment finalised

4. Refund Initiation

   Completed
   07 Oct 2025

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   07 Oct 2025

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   08 Oct 2025

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.